Brian J. Druker describes how his research on imatinib validated protein kinases as therapeutic targets for cancer and led to a life-saving treatment for leukemia. Brian J. Druker Comments & Opinion23 Jan 2025Nature Medicine P: 1-2 Molecular monitoring in CML—a modern example of an old prove...